K C Takarinda1, A D Harries2, C Sandy3, T Mutasa-Apollo3, C Zishiri4. 1. AIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe ; International Union Against Tuberculosis and Lung Disease (The Union), Paris, France. 2. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France ; London School of Hygiene & Tropical Medicine, London, UK. 3. AIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe. 4. The Union, Harare, Zimbabwe.
Abstract
Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004. Objective: To determine whether national ART scale-up was associated with annual national TB case notification rates (CNR), stratified by disease type and category, between 2000 and 2013. Design: This was a retrospective study using aggregate data from global reports. Results: The number of people living with HIV and retained on ART from 2004 to 2013 increased from 8400 to 665 299, with ART coverage increasing from <0.5% to 48%. TB CNRs, all types and categories, increased from 2000 to 2003, and declined thereafter from 2004 to 2013. The decreases in annual TB notifications between the highest rates (before 2004) and lowest rates (2013) were all forms of TB (56%), new TB (60%), previously treated TB (53%), new smear-positive pulmonary TB (PTB) (40%), new smear-negative/smear-unknown PTB (58%) and extra-pulmonary TB (58%). Conclusion: Significant declines in TB CNRs were observed during ART scale-up, especially for smear-negative PTB and extra-pulmonary TB. These encouraging national trends support the continued scale-up of ART for people living with HIV as a way of tackling the twin epidemics of HIV/acquired immune-deficiency syndrome and TB in Zimbabwe.
Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004. Objective: To determine whether national ART scale-up was associated with annual national TB case notification rates (CNR), stratified by disease type and category, between 2000 and 2013. Design: This was a retrospective study using aggregate data from global reports. Results: The number of people living with HIV and retained on ART from 2004 to 2013 increased from 8400 to 665 299, with ART coverage increasing from <0.5% to 48%. TB CNRs, all types and categories, increased from 2000 to 2003, and declined thereafter from 2004 to 2013. The decreases in annual TB notifications between the highest rates (before 2004) and lowest rates (2013) were all forms of TB (56%), new TB (60%), previously treated TB (53%), new smear-positive pulmonary TB (PTB) (40%), new smear-negative/smear-unknown PTB (58%) and extra-pulmonary TB (58%). Conclusion: Significant declines in TB CNRs were observed during ART scale-up, especially for smear-negative PTB and extra-pulmonary TB. These encouraging national trends support the continued scale-up of ART for people living with HIV as a way of tackling the twin epidemics of HIV/acquired immune-deficiency syndrome and TB in Zimbabwe.
Authors: R Zachariah; M Bemelmans; A Akesson; P Gomani; K Phiri; B Isake; T van den Akker; M Philips; A Mwale; F Gausi; J Kwanjana; A D Harries Journal: Int J Tuberc Lung Dis Date: 2011-07 Impact factor: 2.373
Authors: Julia del Amo; Santiago Moreno; Heiner C Bucher; Hansjakob Furrer; Roger Logan; Jonathan Sterne; Santiago Pérez-Hoyos; Inma Jarrín; Andrew Phillips; Sara Lodi; Ard van Sighem; Wolf de Wolf; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; José M Miró; Elena Ferrer; Laurence Meyer; Rémonie Seng; Giota Toulomi; Panagiotis Gargalianos; Dominique Costagliola; Sophie Abgrall; Miguel A Hernán Journal: Clin Infect Dis Date: 2012-03-28 Impact factor: 9.079
Authors: Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye Journal: Arch Intern Med Date: 2003-05-12
Authors: Jonathan E Golub; Valeria Saraceni; Solange C Cavalcante; Antonio G Pacheco; Lawrence H Moulton; Bonnie S King; Anne Efron; Richard D Moore; Richard E Chaisson; Betina Durovni Journal: AIDS Date: 2007-07-11 Impact factor: 4.177
Authors: Rein M G J Houben; Judith R Glynn; Sebastian Mboma; Themba Mzemba; Nimrod J Mwaungulu; Lorren Mwaungulu; Michael Mwenibabu; James Mpunga; Neil French; Amelia C Crampin Journal: AIDS Date: 2012-11-13 Impact factor: 4.177
Authors: Molebogeng X Rangaka; Robert J Wilkinson; Andrew Boulle; Judith R Glynn; Katherine Fielding; Gilles van Cutsem; Katalin A Wilkinson; Rene Goliath; Shaheed Mathee; Eric Goemaere; Gary Maartens Journal: Lancet Date: 2014-05-13 Impact factor: 79.321
Authors: Amitabh B Suthar; Stephen D Lawn; Julia del Amo; Haileyesus Getahun; Christopher Dye; Delphine Sculier; Timothy R Sterling; Richard E Chaisson; Brian G Williams; Anthony D Harries; Reuben M Granich Journal: PLoS Med Date: 2012-07-24 Impact factor: 11.069
Authors: Henry Kanyerere; Anthony D Harries; Katie Tayler-Smith; Andreas Jahn; Rony Zachariah; Frank M Chimbwandira; James Mpunga Journal: Trop Med Int Health Date: 2015-11-16 Impact factor: 2.622
Authors: M Chipinduro; C Timire; J Chirenda; R Matambo; E Munemo; B Makamure; A F Nhidza; W Tinago; V Chikwasha; M Ngwenya; J Mutsvangwa; J Z Metcalfe; C Sandy Journal: Int J Tuberc Lung Dis Date: 2022-01-01 Impact factor: 2.373
Authors: K Rees; N Muditambi; M Maswanganyi; J Railton; J A McIntyre; H E Struthers; P B Fourie; R P H Peters Journal: Epidemiol Infect Date: 2017-12-06 Impact factor: 4.434
Authors: Nazir Ismail; Farzana Ismail; Shaheed V Omar; Linsay Blows; Yasmin Gardee; Hendrik Koornhof; Philip C Onyebujoh Journal: Afr J Lab Med Date: 2018-12-06
Authors: Andrew Tomita; Catherine M Smith; Richard J Lessells; Alexander Pym; Alison D Grant; Tulio de Oliveira; Frank Tanser Journal: Sci Rep Date: 2019-07-24 Impact factor: 4.379
Authors: Bernhard Kerschberger; Michael Schomaker; Alex Telnov; Debrah Vambe; Nicholas Kisyeri; Welile Sikhondze; Lorraine Pasipamire; Siphiwe Mavis Ngwenya; Barbara Rusch; Iza Ciglenecki; Andrew Boulle Journal: Trop Med Int Health Date: 2019-08-07 Impact factor: 2.622
Authors: Anthony D Harries; Yan Lin; Ajay M V Kumar; Srinath Satyanarayana; Kudakwashe C Takarinda; Riitta A Dlodlo; Rony Zachariah; Piero Olliaro Journal: F1000Res Date: 2018-07-05
Authors: Kudakwashe C Takarinda; Anthony D Harries; Tsitsi Mutasa-Apollo; Charles Sandy; Regis C Choto; Simbarashe Mabaya; Cephas Mbito; Collins Timire Journal: BMJ Open Date: 2020-04-06 Impact factor: 2.692